Meda licenses North American rights to new cold sore treatment from Medivir
This article was originally published in Scrip
Executive Summary
Meda has signed an exclusive licensing agreement covering the US, Canada and Mexico for Medivir's cold sore treatment, which will be marketed as Xerese.